
CAS 951385-68-5
:Formula:C22H30N6O4S
InChI:InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)/i10D2,11D2,12D2,13D2
InChI key:BNRNXUUZRGQAQC-BGKXKQMNSA-N
SMILES:[2H]C1(C(N(C(C(N1C)([2H])[2H])([2H])[2H])S(=O)(=O)C2=CC(=C(C=C2)OCC)C3=NC4=C(C(=O)N3)N(N=C4CCC)C)([2H])[2H])[2H]
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
Found 7 products.
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Sildenafil-d8
CAS:Formula:C22H22D8N6O4SColor and Shape:White To Off-White SolidMolecular weight:482.63Sildenafil-d8 (piperazine-d8)
CAS:Purity:99 atom % DColor and Shape:White SolidMolecular weight:482.63Sildenafil-D8
CAS:Sildenafil-D8 is a deuterium-labeled form of Sildenafil (T1164) that can be used for isotope tracing. Sildenafil is a selective phosphodiesterase 5 (PDE5) inhibitor that promotes smooth muscle relaxation by inhibiting the degradation of cyclic guanosine monophosphate (cGMP). Sildenafil-D8 can be used for isotope labeling and pharmacological studies of sildenafil.Formula:C22H22D8N6O4SColor and Shape:SolidMolecular weight:482.63Sildenafil-d8
CAS:Controlled ProductApplications Sildenafil-d8 is the labeled analogue of Sildenafil (S435000), an orally active selective type 5 cGMP phosphodiesterase inhibitor.
References Terrett, N.K., et al.: Bioorg. Med. Chem. Lett., 6, 1819 (1996); Goldstein, I., et al.: N. Engl. J. Med., 338, 1397 (1998)Formula:C22D8H22N6O4SColor and Shape:NeatMolecular weight:482.63Sildenafil-d8
CAS:Controlled ProductSildenafil-d8 is a chemical that is used in medicine. It is the 8-deuterated analog of sildenafil. Sildenafil-d8 has been shown to be more potent than sildenafil in inhibiting phosphodiesterase type-5 (PDE5) and to have a longer half-life. This drug has been shown to be effective in the treatment of pulmonary hypertension, which may be due to its ability to relax smooth muscle cells. Sildenafil-d8 can also be used for the treatment of erectile dysfunction, as it inhibits PDE5, an enzyme that degrades cyclic guanosine monophosphate (cGMP). The effects of this drug are dose dependent and are enhanced by the presence of a matrix effect. This drug is extracted from methanol using liquid chromatography with UV detection at 254 nm and mass spectrometry detection at m/z=Formula:C22H22D8N6O4SPurity:Min. 95%Molecular weight:482.63 g/mol






